Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
The global medical oxygen generator market size was USD 3615.65 million in 2024. The rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis is projected to increase sales to USD 5882.3 million by 2031, with a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. Download a free sample with data verified by Pratik Shirsath
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Type Segment | Pulse Dose, Continuous Flow |
| Application Segment | Home Care, Non-Home Care |
| Technology Segment | PSA Oxygen Generator, Membrane Oxygen Generator, Concentrated Oxygen Generator |
|---|---|
| End User Segment | Hospitals, Clinics, Ambulatory Surgical Centers |
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | xxxx | xxxx | xxxx | 7.2% |
| North America | xxxx | xxxx | xxxx | 5.4% |
| United States | xxxx | xxxx | xxxx | 5.2% |
| Canada | xxxx | xxxx | xxxx | 6.2% |
| Mexico | xxxx | xxxx | xxxx | 5.9% |
| Europe | xxxx | xxxx | xxxx | 5.7% |
| United Kingdom | xxxx | xxxx | xxxx | 6.5% |
| France | xxxx | xxxx | xxxx | 4.9% |
| Germany | xxxx | xxxx | xxxx | 5.9% |
| Italy | xxxx | xxxx | xxxx | 5.1% |
| Russia | xxxx | xxxx | xxxx | 4.7% |
| Spain | xxxx | xxxx | xxxx | 4.8% |
| Sweden | xxxx | xxxx | xxxx | xxxx |
| Denmark | xxxx | xxxx | xxxx | xxxx |
| Switzerland | xxxx | xxxx | xxxx | xxxx |
| Luxembourg | xxxx | xxxx | xxxx | xxxx |
| Rest of Europe | xxxx | xxxx | xxxx | 4.4% |
| Asia Pacific | xxxx | xxxx | xxxx | 9.2% |
| China | xxxx | xxxx | xxxx | 8.7% |
| Japan | xxxx | xxxx | xxxx | 7.7% |
| South Korea | xxxx | xxxx | xxxx | 8.3% |
| India | xxxx | xxxx | xxxx | 11% |
| Australia | xxxx | xxxx | xxxx | 8.9% |
| Singapore | xxxx | xxxx | xxxx | xxxx |
| Taiwan | xxxx | xxxx | xxxx | xxxx |
| South East Asia | xxxx | xxxx | xxxx | xxxx |
| Rest of APAC | xxxx | xxxx | xxxx | 9% |
| South America | xxxx | xxxx | xxxx | 6.6% |
| Brazil | xxxx | xxxx | xxxx | 7.2% |
| Argentina | xxxx | xxxx | xxxx | 7.5% |
| Colombia | xxxx | xxxx | xxxx | 6.4% |
| Peru | xxxx | xxxx | xxxx | 6.8% |
| Chile | xxxx | xxxx | xxxx | 6.9% |
| Rest of South America | xxxx | xxxx | xxxx | 5.7% |
| Middle East | xxxx | xxxx | xxxx | 6.9% |
| Saudi Arabia | xxxx | xxxx | xxxx | xxxx |
| Turkey | xxxx | xxxx | xxxx | 6.4% |
| UAE | xxxx | xxxx | xxxx | xxxx |
| Egypt | xxxx | xxxx | xxxx | 7.2% |
| Qatar | xxxx | xxxx | xxxx | xxxx |
| Rest of Middle East | xxxx | xxxx | xxxx | 5.9% |
| Africa | xxxx | xxxx | xxxx | xxxx |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | xxxx | xxxx | xxxx | xxxx |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Medical Oxygen Generator Market Type Segment Analysis According to Cognitive Market Research, the pulse dose oxygen generators segment holds a dominant position in the global market. This type of oxygen delivery system is designed to release oxygen only when the patient inhales, ensuring efficiency in oxygen use. Pulse dose systems are more energy-efficient as they deliver oxygen in short bursts rather than a continuous flow, which makes them ideal for portable and home healthcare applications. This mode is particularly favoured by patients who require supplemental oxygen for chronic respiratory conditions like COPD, where the demand for oxygen is intermittent. The continuous flow segment is the fastest-growing category within the medical oxygen generator market. Unlike pulse dose systems, continuous flow generators provide a steady stream of oxygen to the patient, regardless of inhalation. This makes them suitable for patients with more severe or constant oxygen needs, such as those in acute care settings or intensive care units (ICU). Moreover, continuous flow oxygen systems are largely being adapted for use in home healthcare settings, which is fueling their rapid expansion, particularly in regions with an ageing population.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The medical oxygen generator industry is highly competitive, with a diverse mix of established multinational corporations, specialised medical device manufacturers, and emerging regional players. Companies in this market are focusing on innovation, with heavy investments in R&D projects to improve oxygen generator efficiency, portability, and ease of use, catering to both hospital-based and home healthcare applications. Leading players are actively involved in strategic partnerships, collaborations, and acquisitions to expand their market presence and tap into new customer bases.
Koninklijke Philips N.V., Chart Industries, Inc., Inogen Inc., Invacare Corporation, and ResMed Inc. are the key players in the Medical Oxygen Generator Market
Holding a commanding 15% share in the medical oxygen generator market, Koninklijke Philips N.V. stands out as a global leader in healthcare technology and patient care solutions. The Dutch multinational leverages its extensive expertise in respiratory and critical care to offer cutting-edge oxygen concentrators and generators tailored for both hospital and home use. Philips’ flagship products, including the Philips Respironics line, are recognized for their portability, energy efficiency, and advanced oxygen delivery capabilities. The company’s focus on innovation has enabled it to lead the shift toward patient-centric and connected care. Philips integrates smart features into its oxygen generators, allowing remote monitoring and real-time adjustments, which enhance patient outcomes and reduce hospital visits. Its global distribution network, strong clinical partnerships, and robust after-sales service contribute significantly to its leadership in developed and emerging markets alike. Philips places high priority on product quality, safety, and regulatory compliance, aligning with global healthcare standards such as FDA, CE, and ISO certifications. In addition to product excellence, the company is committed to sustainability and cost-effective healthcare delivery. With its solid brand equity, technological strength, and patient-first approach, Philips continues to redefine standards in oxygen therapy, reinforcing its top-tier position in the medical oxygen generator landscape.
Chart Industries, Inc. holds a 13% market share in the medical oxygen generator segment, known globally for its advanced cryogenic and gas processing technologies. The U.S.-based company provides robust, high-capacity oxygen generation systems used in hospitals, clinics, and field medical facilities. Chart’s product lines include on-site Pressure Swing Adsorption (PSA) oxygen generators, vacuum-insulated storage tanks, and related delivery systems that ensure continuous and reliable medical oxygen supply. A key differentiator for Chart Industries is its emphasis on engineering excellence and scalable solutions. Its generators are designed to function efficiently under demanding conditions and are favored in regions with limited access to bottled oxygen. Chart’s systems often serve as the backbone of hospital gas supply infrastructures, especially in rural and developing areas where centralized systems are not viable. The company also focuses on sustainability and reducing the carbon footprint of gas delivery systems. With growing demand for oxygen during public health crises and emergencies, Chart has rapidly scaled up production capacity while maintaining quality and compliance with international health and safety regulations. Its commitment to customization, energy efficiency, and lifecycle support makes it a preferred partner for healthcare providers looking for long-term oxygen generation solutions.
Inogen Inc., with a 12% market share, has become a recognized name in the medical oxygen generator market, particularly for its innovation in portable oxygen concentrators (POCs). Based in California, Inogen focuses on empowering patients with respiratory disorders by offering lightweight, user-friendly oxygen delivery systems that support mobility and independence. Its products, including the Inogen One series, are among the most compact and travel-approved POCs available in the market. Inogen’s strategy centers on direct-to-consumer engagement and digital marketing, which allows the company to build strong brand loyalty while reducing dependency on third-party distributors. The firm also supports rental programs and long-term care providers, expanding its presence across homecare settings and eldercare institutions. Its technology integrates intelligent delivery systems that adjust oxygen flow based on real-time patient breathing patterns, optimizing therapeutic outcomes. With approvals from regulatory bodies like the FDA and FAA, Inogen has expanded rapidly across North America, Europe, and parts of Asia-Pacific. Continuous investment in R&D, a streamlined supply chain, and growing customer service infrastructure allow Inogen to stay competitive in both premium and mid-range market segments. The company’s blend of portability, innovation, and patient-centric design keeps it at the forefront of modern oxygen therapy solutions.
Invacare Corporation commands an 11% share in the global medical oxygen generator market, leveraging its longstanding reputation in mobility and respiratory care. Headquartered in Ohio, USA, Invacare specializes in a wide array of oxygen concentrators and homecare respiratory products designed for patients with chronic obstructive pulmonary disease (COPD), asthma, and other long-term respiratory illnesses. Its Platinum and Perfecto series concentrators are especially popular in both homecare and institutional settings. Invacare’s strength lies in designing reliable, quiet, and energy-efficient machines that prioritize user convenience. The company has made consistent efforts to enhance the durability and transportability of its units, addressing the needs of aging populations and at-home patients seeking consistent oxygen therapy. Invacare's offerings are widely approved for use under various international healthcare standards, ensuring global appeal and compliance. Beyond product innovation, Invacare invests significantly in training programs and customer support, helping caregivers and healthcare workers optimize device use. The company also leverages distribution partnerships and digital channels to increase its reach in both mature and developing healthcare markets. Its ability to provide holistic respiratory care from equipment to support services ensures Invacare remains a trusted name in the medical oxygen generator ecosystem.
ResMed Inc., holding a 10% market share, is an established leader in digital health and respiratory care solutions, known primarily for its sleep apnea devices but increasingly influential in the medical oxygen generator market. Headquartered in San Diego, California, ResMed offers portable and stationary oxygen concentrators under its ever-expanding respiratory care portfolio. Its offerings are engineered to enhance patient adherence, especially among those with sleep-related breathing disorders requiring supplemental oxygen. ResMed’s AirCurve and Mobi series of oxygen solutions are distinguished by their intelligent flow control, lightweight design, and integration with cloud-based patient monitoring platforms. These features allow healthcare providers to track oxygen usage and therapy effectiveness remotely, aligning with the growing trend of connected health. The company’s commitment to digital transformation has helped healthcare professionals and caregivers reduce emergency hospital visits and improve overall patient management. The brand is widely trusted across North America, Europe, and Australia, and is expanding in emerging markets where chronic respiratory illnesses are on the rise. ResMed continues to invest in smart diagnostics, AI-driven therapy optimization, and cross-platform device compatibility. Its data-driven, patient-centric approach ensures that ResMed not only meets medical oxygen needs but also contributes meaningfully to broader healthcare efficiency.
Innovation, Affordability, and Regional Customization are Key Focus Areas for New Entrants in the Medical Oxygen Generator Market
New entrants aiming to establish a foothold in the medical oxygen generator market must prioritize advanced technology development, cost efficiency, and region-specific solutions. Creating oxygen generators that incorporate energy-efficient compressors, improved filtration systems, and smart monitoring capabilities can provide superior performance while reducing operational costs. Cost competitiveness is essential, especially for penetrating emerging markets where healthcare budgets are constrained. Sourcing high-quality yet affordable components and optimizing manufacturing processes will enable new players to offer economically viable options without compromising reliability or compliance with medical standards.
Regional customization is another critical success factor. Understanding local healthcare infrastructure challenges and regulatory environments allows new entrants to tailor products to specific market needs. Portable and user-friendly oxygen generators suited for homecare in developed countries or rugged, easy-maintenance units for rural areas in developing regions can unlock significant growth opportunities. Building strong partnerships with healthcare providers, distributors, and governmental health programs will facilitate market entry and enhance product adoption. Furthermore, educating end-users and healthcare workers on the benefits and safe operation of oxygen generators can drive trust and demand. Investing in after-sales service networks and remote monitoring technologies also improves customer satisfaction and retention, critical factors in a market where device reliability directly impacts patient health. By focusing on technological innovation, affordability, tailored solutions, and strategic partnerships, new entrants can successfully navigate the competitive medical oxygen generator market.
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Air Liquide (France) | ••• | ••• | ••• | ••• |
| Linde plc (Ireland) | ••• | ••• | ••• | ••• |
| Inogen Inc. (U.S.) | ••• | ••• | ••• | ••• |
| Atlas Copco (Sweden) | ••• | ••• | ••• | ••• |
| Precision Medical Inc. (U.S.) | ••• | ••• | ••• | ••• |
| Invacare Corporation (U.S.) | ••• | ••• | ••• | ••• |
| Oxymat A/S (Denmark) | ••• | ••• | ••• | ••• |
| NGK Spark Plug Co. Ltd. (Japan) | ••• | ••• | ••• | ••• |
| Oxygen Generating Systems Intl. (OGSI) (U.S.) | ••• | ••• | ••• | ••• |
| CAIRE Inc. (U.S.) | ••• | ••• | ••• | ••• |
| Yantai Beacon Medical Technology Co. Ltd. (China) | ••• | ••• | ••• | ••• |
| Oxywise | ••• | ••• | ••• | ••• |
| s.r.o. (Slovakia) | ••• | ••• | ••• | ••• |
| Nidek Medical Products Inc. (U.S.) | ••• | ••• | ••• | ••• |
| GCE Group (Sweden) | ••• | ••• | ••• | ••• |
| O2 Concepts LLC (U.S.) | ••• | ••• | ••• | ••• |
| Bhuruka Gases Ltd. (India) | ••• | ••• | ••• | ••• |
| Oxair Gas Systems Pty Ltd (Australia) | ••• | ••• | ••• | ••• |
| SOGE Médical (France) | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →According to Cognitive Market Research, the global medical oxygen generator market size was USD 3615.65 million in 2024. It will expand at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.
The medical oxygen generator market encompasses devices and systems designed to produce medical-grade oxygen, primarily for healthcare facilities, emergency services, and home care applications. These generators are used to provide a steady, on-site source of oxygen, eliminating the need for constant deliveries of oxygen cylinders. Oxygen generators play a major role in respiratory care, emergency response, and chronic disease management, particularly for patients with conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory ailments. Factors such as a rising prevalence of respiratory diseases, an ageing population, and a growing focus on home-based care solutions have fueled market demand for these systems. Moreover, recent advancements in portable and energy-efficient oxygen generator technologies and supportive government healthcare initiatives are also contributing to sustained market expansion.
In July 2022, OMRON Healthcare, a global pioneer in home blood pressure monitoring and cardiovascular disease management, announced the release of its latest innovation in the oxygen treatment category. The company launched a portable oxygen concentrator, a medical gadget that provides continuous high-purity oxygen delivery to patients suffering from COPD and respiratory issues. This newly developed portable oxygen concentrator provides a continuous supply of high-purity oxygen with a concentration output of more than 90%. (Source: https://healthwire.co/lets-talk-health/omron-healthcare-introduces-high-quality-portable-oxygen-concentrator/)
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Medical Oxygen Generator Market Analysis is witnessing significant growth in the near future.
In 2023, the Pulse Dose segment accounted for a notable share of the Medical Oxygen Generator Market Analysis.
Pratik Shirsath serves as a Research Analyst at Cognitive Market Research & Consulting, where he focuses on the Machinery & Equipment, Manufacturing, and Construction sectors. His work centers on delivering strategic market intelligence that helps organizations understand evolving industry dynamics, technological advancements, and emerging growth opportunities across industrial and infrastructure markets. By combining primary research with extensive secondary analysis, he develops data-driven insights that support informed business decision-making.
Drawing on experience across industrial value chains, Pratik conducts market assessments, competitive evaluations, trend analysis, stakeholder research, and opportunity mapping for clients operating in complex engineering and manufacturing environments. He regularly engages with manufacturers, equipment suppliers, industry experts, contractors, distributors, and other market participants to gather firsthand perspectives while validating findings through comprehensive secondary research. His ability to interpret technical and commercial data enables organizations to gain a clearer understanding of market conditions, investment trends, and competitive developments.
As part of his role, Pratik contributes to syndicated research studies, custom consulting projects, and strategic market reports covering industrial machinery, factory automation, manufacturing technologies, construction equipment, building materials, and infrastructure-related markets. His analytical approach helps clients evaluate market potential, identify expansion opportunities, assess competitive positioning, and navigate industry challenges with greater confidence.
Known for transforming complex datasets and technical information into actionable business intelligence, Pratik supports organizations in developing effective growth strategies and operational plans. His continued focus on industrial innovation, automation technologies, sustainable manufacturing practices, and evolving construction trends enables him to deliver valuable research that helps businesses adapt to changing market environments and achieve long-term success.
★ Reviews
Rate this report
| Type | Pulse Dose, Continuous Flow |
|---|---|
| Application | Home Care, Non-Home Care |
| Technology | PSA Oxygen Generator, Membrane Oxygen Generator, Concentrated Oxygen Generator |
| End User | Hospitals, Clinics, Ambulatory Surgical Centers |
| List of Competitors | Air Liquide (France), Linde plc (Ireland), Inogen Inc. (U.S.), Atlas Copco (Sweden), Precision Medical Inc. (U.S.), Invacare Corporation (U.S.), Oxymat A/S (Denmark), NGK Spark Plug Co. Ltd. (Japan), Oxygen Generating Systems Intl. (OGSI) (U.S.), CAIRE Inc. (U.S.), Yantai Beacon Medical Technology Co. Ltd. (China), Oxywise, s.r.o. (Slovakia), Nidek Medical Products Inc. (U.S.), GCE Group (Sweden), O2 Concepts LLC (U.S.), Bhuruka Gases Ltd. (India), Oxair Gas Systems Pty Ltd (Australia), SOGE Médical (France) |
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Pratik Shirsath and team for the Medical Oxygen Generator Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
The global Medical Oxygen Generator market is gaining considerable traction driven by the rising demand for on site oxygen production in hospitals clinics and emergency care settings
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Medical Oxygen Generator Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the medical oxygen generator market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
